talotrexin has been researched along with 5,10-methylenetetrahydrofolic acid in 1 studies
| Studies (talotrexin) | Trials (talotrexin) | Recent Studies (post-2010) (talotrexin) | Studies (5,10-methylenetetrahydrofolic acid) | Trials (5,10-methylenetetrahydrofolic acid) | Recent Studies (post-2010) (5,10-methylenetetrahydrofolic acid) |
|---|---|---|---|---|---|
| 27 | 0 | 4 | 214 | 10 | 35 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alperin, WL; Pardo, M; Rosowsky, A; Tretyakov, A; Trites, D; Wright, JE | 1 |
1 other study(ies) available for talotrexin and 5,10-methylenetetrahydrofolic acid
| Article | Year |
|---|---|
Pharmacokinetics, antifolate activity and tissue distribution of PT523 in SCC VII tumor-bearing mice.
Topics: Animals; Antineoplastic Agents; Area Under Curve; Carbon Radioisotopes; Carcinoma, Squamous Cell; Folic Acid Antagonists; Injections, Intravenous; Isotope Labeling; Male; Methotrexate; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Ornithine; Pterins; Tetrahydrofolates; Tissue Distribution | 1998 |